Celebrating 20 Years of AFTD’s Pilot Grant Program

Title Graphic: Celebrating 20 Years of AFTD’s Pilot Grant Program

Over the past 20 years, AFTD’s Pilot Grant program, which supports early-career researchers or new ideas, has funded $2.8 million in innovative FTD research. In 2005, AFTD founder Helen-Ann Comstock and a small group of medical advisors awarded $35,000 to Eileen Bigio, MD, a clinical researcher at Northwestern University, to identify abnormal proteins present in…

Read More

Celebrating 20 Years of AFTD’s Pilot Grant Program

Title Graphic: Celebrating 20 Years of AFTD’s Pilot Grant Program

Over the past 20 years, AFTD’s Pilot Grant program, which supports early-career researchers or new ideas, has funded $2.8 million in innovative FTD research. In 2005, AFTD founder Helen-Ann Comstock and a small group of medical advisors awarded $35,000 to Eileen Bigio, MD, a clinical researcher at Northwestern University, to identify abnormal proteins present in…

Read More

Advancing Hope: FTD and ALS Joint Initiatives

Text: Advancing Hope - FTD and ALS Joint Initiatives | Background: A doctor shows a tablet with an MRI result to a patient

Did you know that certain cellular changes that occur in FTD are also observed in Amyotrophic Lateral Sclerosis (ALS)? In some cases, neurodegeneration in ALS and FTD is linked to aggregation and impairment of a protein known as TDP-43. Furthermore, there are genetic mutations linked to onset of one or both diseases. With these and…

Read More

The Lived Experience of FTD: Managing Anxiety

Text: The Lived Experience of FTD - Managing Anxiety | Background: A woman sits leaning against the foot of her bed in contemplation

The following article was written by Chris Tann, a member of AFTD’s Persons With FTD Advisory Council. You can learn more about Chris and the other members of the Council on AFTD’s website. Anxiety is something that people living with FTD may experience on their journey. I have not been in the company of anyone,…

Read More

Two Drugs Selected for Evaluation in Platform Trial for PSP

Title: Two Drugs Selected for Evaluation in Platform Trial for PSP | Background: A team of scientists work in a lab - two discuss their work while the third uses a microscope

A pair of drugs has been selected for evaluation in a platform trial that aims to accelerate the development of treatments for progressive supranuclear palsy (PSP). The trial is being conducted by researchers at the University of California, San Francisco; the University of California, San Diego; and Massachusetts General Hospital. Drugs for Other Tauopathies Might…

Read More

Dear HelpLine: Hospice Care and FTD

Text: Dear HelpLine - Hospice Care for FTD | Background: A healthcare provider holds someone's hands during an appointment

Dear HelpLine, My sister has had FTD for a few years, and her doctor recently told us we should consider moving her to hospice. What does hospice care involve? How has the experience gone for others? Hospice offers holistic care that focuses on maximizing the quality of one’s remaining life by addressing physical symptoms and…

Read More

Study Evaluates PET Tracer and Explores How PSP Damages Brain Synapses

Text: Study Evaluates PET Tracer and Explores How PSP Damages Brain Synapses | Background: A researcher looks through a microscope

A study published in the journal Alzheimer’s & Dementia evaluates the potential utility of a novel PET tracer for progressive supranuclear palsy (PSP) while also exploring how the disorder damages synapses.   The Mechanisms of Synaptic Loss in PSP are Unknown  Synapses are the junctions that connect neurons, transmitting electrical or chemical signals to assist with…

Read More

Former Judge Gains Artistic Ability after PPA Diagnosis

Title of the article, against background of artwork by Dylan Sullivan, "Colored Pencils 1"

A former judge in Folsom, Calif., has discovered a newfound talent for visual art following a diagnosis of primary progressive aphasia, KCRA in Sacramento reported earlier this year. Two years ago, Dylan Sullivan would never have called herself an artist. As a judge in El Dorado, Calif. Superior Court, her world was the law, her…

Read More

2025 Colfax Marathon

The AFTD-Team will participate in the Colfax Marathon on May 17-18, as an Official Charity Partner. We hope you’ll join us for a weekend of connection and awareness. Race distances include: Marathon (26.2 miles); Half Marathon (13.1 miles); Urban 10-Miler; 5K (3.1 miles); and Marathon Relay (26.2 miles across five individual legs). Click here to…

Read More

BRI Care Consultation Learning Collaborative – Understanding FTD: Diagnosis, Support and Resources for Patients and Caregivers

BRI Care Consultation logo

Join AFTD Director of Support and Education Esther Kane, MSN, RN-CDP for a free informative session highlighting the signs and symptoms of FTD, how it is diagnosed, and what resources are available for families on the FTD journey, presented by the Benjamin Rose Institute on Aging. A Q&A session will be held to allow attendees…

Read More